Literature DB >> 26549268

Prescription patterns of traditional Chinese medicine for peptic ulcer disease in Taiwan: A nationwide population-based study.

Chin-Ying Huang1, Wan-Yu Lai2, Mao-Feng Sun3, Che-Chen Lin4, Bor-Chyuan Chen5, Hung-Jen Lin6, Ching-Mao Chang7, Chung-Hsien Yang6, Kuo-Chin Huang8, Hung-Rong Yen9.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Peptic ulcer disease is a common digestive disease. There is a lack of large-scale survey on the use of traditional Chinese medicine (TCM) for the treatment of peptic ulcer disease. This study aimed to investigate the utilization of TCM for the treatment of peptic ulcer disease in Taiwan.
MATERIALS AND METHODS: We analyzed a random sample comprised of one million individuals with newly diagnosed peptic ulcer disease between 2001 and 2010 from the National Health Insurance Research Database in Taiwan. Demographic characteristics and TCM usage, including Chinese herbal formulas and the single herbs prescribed for patients with peptic ulcer disease, were analyzed.
RESULTS: A total of 96,624 newly diagnosed subjects with peptic ulcer disease were included. 14,983 (15.5%) patients were TCM users. People residing in highly urbanized areas, younger people and female (compared with male) were more likely to use TCM. With regard to the comorbidities, TCM users had a lower prevalence of coronary artery disease, chronic obstructive lung disease, diabetes mellitus and liver cirrhosis and stroke. The average time between onset of peptic ulcer disease and the first visit to a TCM clinic was 4.7 months. Majority of the patients (n=14,449; 96.4%) received only Chinese herbal remedies. The most frequently prescribed Chinese herbal formula and single herb was Ban-Xia-Xie-Xin-Tang (Pinelliae Decoction to Drain the Epigastrium) and Hai-Piao-Xiao (Os Sepiae), respectively. The core pattern analysis showed that combination of Ban-Xia-Xie-Xin-Tang, Hai-Piao-Xiao (Os Sepiae), Yan-Hu-Suo (Rhizoma Corydalis), Bei-Mu (Bulbus Fritillariae Thunbergii) and Chuan-Lian-Zi (Fructus Toosendan) was most frequently used for peptic ulcer disease.
CONCLUSIONS: Our study identified the core prescription patterns of TCM for patients with peptic ulcer disease in Taiwan. Further basic and clinical studies are necessary to elucidate the efficacy and mechanisms.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ban-Xia-Xie-Xin-Tang; Complementary and alternative medicine; National health insurance research database; Os Sepiae; Peptic ulcer disease; Traditional Chinese medicine

Mesh:

Substances:

Year:  2015        PMID: 26549268     DOI: 10.1016/j.jep.2015.11.002

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.

Authors:  Hyeong Sim Choi; Min Kyoung Kim; Kangwook Lee; Kang Min Lee; Youn Kyung Choi; Yong Cheol Shin; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Oncotarget       Date:  2016-05-31

2.  Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study.

Authors:  Shu-Wen Weng; Bor-Chyuan Chen; Yu-Chiao Wang; Chun-Kai Liu; Mao-Feng Sun; Ching-Mao Chang; Jaung-Geng Lin; Hung-Rong Yen
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-16       Impact factor: 2.629

3.  Efficacy and safety of Jianzhong decoction in treating peptic ulcers: a meta-analysis of 58 randomised controlled trials with 5192 patients.

Authors:  Yan Sun; Jinping Zhang; Yuanyuan Chen
Journal:  BMC Complement Altern Med       Date:  2017-04-14       Impact factor: 3.659

4.  Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study.

Authors:  Tom Fleischer; Tung-Ti Chang; Jen-Huai Chiang; Mao-Feng Sun; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2016-08-16       Impact factor: 3.279

5.  Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study.

Authors:  Yi-Ting Kuo; Hou-Hsun Liao; Jen-Huai Chiang; Mei-Yao Wu; Bor-Chyuan Chen; Ching-Mao Chang; Ming-Hsien Yeh; Tung-Ti Chang; Mao-Feng Sun; Chia-Chou Yeh; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2017-08-03       Impact factor: 3.279

6.  A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Ban-Xia-Xie-Xin-Tang.

Authors:  Ming Yang; Jialei Chen; Liwen Xu; Xiufeng Shi; Xin Zhou; Rui An; Xinhong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-16       Impact factor: 2.629

7.  Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study.

Authors:  Yi-Ting Kuo; Tung-Ti Chang; Chih-Hsin Muo; Mei-Yao Wu; Mao-Feng Sun; Chia-Chou Yeh; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2017-06-30       Impact factor: 3.279

8.  Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study.

Authors:  Ai-Lin Lee; Bor-Chyuan Chen; Chih-Hsin Mou; Mao-Feng Sun; Hung-Rong Yen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

9.  Complementary traditional Chinese medicine use in Children with cerebral palsy: a nationwide retrospective cohort study in Taiwan.

Authors:  Hou-Hsun Liao; Hung-Rong Yen; Chih-Hsin Muo; Yu-Chen Lee; Mei-Yao Wu; Li-Wei Chou; Mao-Feng Sun; Tung-Ti Chang
Journal:  BMC Complement Altern Med       Date:  2017-03-14       Impact factor: 3.659

10.  'Psoriasis 1' reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways.

Authors:  Wen Sun; Yang Gao; Xianhua Yu; Yuan Yuan; Jun Yi; Zhen Zhang; Yuxing Cheng; Yong Li; Xing Peng; Xushan Cha
Journal:  Mol Med Rep       Date:  2018-07-09       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.